• Markets
  • icon
  • Companies
IPD · ASX

Impedimed Limited (ASX:IPD)

AU$0.089

 0.001 (1.136%)
ASX:Live
17/05/2024 04:10:34 PM
HALO Ords HALO Consensus Value GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

IPD Overview

IPD Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About IPD

Telephone

Address

Description

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. Its product SOZO, uses bioimpedance spectroscopy technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. The company was founded by Melvyn John Bridges and Lucille Mayse Bridges on September 27, 1999 and is headquartered in Pinkenba, Australia.

IPD Price Chart

Key Stats

Market Cap

AU$178.03M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.08 - 0.24

Trade Value (12mth)

AU$98,720.00

1 week

12.66%

1 month

-4.3%

YTD

-38.62%

1 year

-34.07%

All time high

1.7366199493408203

Key Fundamentals

EPS 3 yr Growth

-68.200%

EBITDA Margin

-179.60%

Operating Cashflow

-$18m

Free Cash Flow Return

-31.90%

ROIC

-36.30%

Interest Coverage

-599.40

Quick Ratio

8.70

Other Data

Shares on Issue (Fully Dilluted)

1998m

HALO Sector

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.97

IPD Announcements

Latest Announcements

Date Announcements

15 May 24

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

×

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

13 May 24

Change of Director's Interest Notice - Ms Janelle Delaney

×

Change of Director's Interest Notice - Ms Janelle Delaney

13 May 24

Change of Director's Interest Notice - Mr Andrew Grant

×

Change of Director's Interest Notice - Mr Andrew Grant

30 April 24

Quarterly Activities Report and Appendix 4C - March-2024 Qtr

×

Quarterly Activities Report and Appendix 4C - March-2024 Qtr

30 April 24

Investor Presentation

×

Investor Presentation

22 April 24

Notification of Quarterly Results & Investor, Revised

×

Notification of Quarterly Results & Investor, Revised

19 April 24

Notification of Quarterly Results & Investor Conference Call

×

Notification of Quarterly Results & Investor Conference Call

17 April 24

Organisational Changes

×

Organisational Changes

12 April 24

Notification of cessation of securities - IPD

×

Notification of cessation of securities - IPD

27 March 24

Change of Director's Interest Notice - Ms Janelle Delaney

×

Change of Director's Interest Notice - Ms Janelle Delaney

13 March 24

Change in substantial shareholding from AEF

×

Change in substantial shareholding from AEF

12 March 24

Change in substantial holding

×

Change in substantial holding

11 March 24

Notification of cessation of securities - IPD

×

Notification of cessation of securities - IPD

11 March 24

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

×

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

11 March 24

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

×

Impedimed Limited - Notification of cessation of securities - IPD (IPD-AU)

08 March 24

Revised Change of Director's Interest Notice-Mr A Grant

×

Revised Change of Director's Interest Notice-Mr A Grant

05 March 24

Change of Director's Interest Notice - Ms Janelle Delaney

×

Change of Director's Interest Notice - Ms Janelle Delaney

04 March 24

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

×

Change of Director's Interest Notice - Ms Emmanuel-Donnelly

01 March 24

Change of Director's Interest Notice - Mr Andrew Grant

×

Change of Director's Interest Notice - Mr Andrew Grant

01 March 24

S&P DJI Announces March 2024 Quarterly Rebalance

×

S&P DJI Announces March 2024 Quarterly Rebalance

27 February 24

Appendix 4D and Interim Financial Report

×

Appendix 4D and Interim Financial Report

27 February 24

ImpediMed 2024 Half-Year Financial Results

×

ImpediMed 2024 Half-Year Financial Results

27 February 24

Investor Presentation

×

Investor Presentation

26 February 24

Appointment of Chair

×

Appointment of Chair

22 February 24

Notification of buy-back - IPD

×

Notification of buy-back - IPD

IPD Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 52.1 31.4 3.4 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 37.9 24.2 -10.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -10.6 -15.4 -5.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.03 0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.02 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -41.8 84.3 2.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,202 1,679 1,800 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,202 1,679 1,800 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 8 11 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 46.5 25.7 7.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 11 8 9 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -12 -13 -14 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.3 -9.4 -2.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -145.1 -126.3 -120.4 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 245 226 220 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -21 -18 -20 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.5 13.4 -10.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -253.5 -174.7 -179.6 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 3 2 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -23 -21 -23 Lock Lock Lock
     Growth % Lock Lock Lock Lock 9.8 7.8 -7.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -273.7 -200.9 -201.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -22 -21 -22 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -2 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -21 -20 -21 Lock Lock Lock
     Growth % Lock Lock Lock Lock 3.1 4.0 -3.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -246.2 -188.1 -180.9 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -13 -16 -18 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 2 5 6 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -2 -5 -6 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 16 40 28 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -13 -16 -18 Lock Lock Lock
     Growth % Lock Lock Lock Lock 31.0 -18.0 -17.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -1.6 -1.5 -1.6 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 20 41 46 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 34 59 69 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -19 -41 -44 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 9 8 8 Lock Lock Lock
Equity $m Lock Lock Lock Lock 26 51 61 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 26 51 62 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.9 98.8 21.5 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -60.5 -33.9 -29.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -81.2 -38.9 -33.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -84.9 -55.0 -40.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -77.3 -51.8 -36.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -49.5 -40.8 -31.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -409.9 -659.2 -599.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.9 2.2 2.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -75.3 -79.5 -72.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.2 6.4 8.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.1 6.3 8.7 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 76.7 87.3 88.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -163.0 -216.3 -308.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.8 2.4 2.6 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 33.4 36.9 28.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.5 0.3 0.2 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 15.4 25.0 11.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.2 0.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -267.0 -203.0 -194.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -65.6 -36.5 -32.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -60.5 -33.9 -29.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -81.2 -38.9 -33.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -81.2 -38.9 -33.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 10.9 9.9 12.7 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 197.8 155.1 141.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 208.8 165.0 153.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 29.1 29.3 29.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 179.7 135.7 124.4 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.97%

Value ($M)

2

Prior Change

N/A

7 Day Change

N/A

1 Month Change

0.30%

3 Month Change

0.50%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IPD Shortsell

Frequently Asked Questions

The current share price of Impedimed Limited (IPD:ASX) is AU$0.089.
The 52-week high share price for Impedimed Limited (IPD:ASX) is AU$0.24.
The 52-week low share price for Impedimed Limited (IPD:ASX)? is AU$0.08.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) does not pay a dividend.
Impedimed Limited (IPD:ASX) has a franking level of 0.0%.
Impedimed Limited (IPD:ASX) is classified in the Healthcare.
The current P/E ratio for Impedimed Limited (IPD:ASX) is .